A detailed history of Pfg Investments, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 134,125 shares of ARDX stock, worth $690,743. This represents 0.06% of its overall portfolio holdings.

Number of Shares
134,125
Previous 134,125 -0.0%
Holding current value
$690,743
Previous $994 Million 7.02%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$6.05 - $9.74 $176,508 - $284,164
-29,175 Reduced 17.87%
134,125 $979 Million
Q4 2023

Jan 17, 2024

BUY
$3.29 - $6.64 $3,783 - $7,636
1,150 Added 0.71%
163,300 $1.01 Billion
Q3 2023

Nov 06, 2023

BUY
$3.3 - $4.83 $40,755 - $59,650
12,350 Added 8.24%
162,150 $662 Million
Q2 2023

Aug 03, 2023

SELL
$3.23 - $4.95 $29,070 - $44,550
-9,000 Reduced 5.67%
149,800 $508 Million
Q1 2023

May 11, 2023

BUY
$2.68 - $4.79 $425,584 - $760,652
158,800 New
158,800 $761 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $796M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.